首页 工具
登录
购物车

搜索结果

Search Results for " mk2 inhibitor "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T36778 MK2-IN-1

MK2-IN-1 (MK2 Inhibitor)

MK2-IN-1 is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.
T4442 MK2-IN-1 hydrochloride

MK2 Inhibitor,MK 25

MAPK MAPK
MK2-IN-1 hydrochloride (MK 25) 是一种高效的选择性 MAPKAPK2(MK2)激酶抑制剂,其 IC50值为0.11uM。
T9034 MK2-IN-3

MK2 Inhibitor III

MAPK MAPK
MK2-IN-3 (MK2 Inhibitor III) 是选择性的 MAPKAP-K2 (MK-2)抑制剂(IC50:8.5 nM),能够抑制 U937 细胞及体内 TNFα 的生成。
T12058 MK2-IN-3 hydrate

MK-2 Inhibitor III

ERK; MAPK; MNK MAPK
MK2-IN-3 hydrate (MK-2 Inhibitor III) 是一种口服有活性的、ATP 竞争性的MAPKAP-K2 (MK-2)选择性抑制剂(IC50:0.85 nM)。
T14988 CMPD1

MAPK MAPK
CMPD1 是非 ATP 竞争性 p38 MAPK 介导的 MK2磷酸化选择性抑制剂(Ki:330 nM)。
T81783 MK2-IN-5

Hsp25 kinase inhibitor,Mk2 pseudosubstrate

ERK MAPK
MK2-IN-5为Mk2的假底物,Ki值为8 μM。该化合物针对MAPK通路内的蛋白相互作用域,并能抑制HSP25与HSP27的磷酸化。
T16501 PF-3644022

p38 MAPK; Serine Protease; MAPK MAPK; Proteases/Proteasome
PF-3644022 是可口服的,具有 ATP 竞争性的MAPKAPK2 (MK2)选择性抑制剂,IC50为 5.2 nM,Ki 为 3 nM。它有效抑制 TNFα 的产生并具有抗炎作用,还抑制 MK3 和 p38 调节/激活激酶,IC50分别为 53 和 5.0 nM。
T60657 (R)-STU104

TNF; MAPK Apoptosis; MAPK
(R)-STU104 是一种新型 TAK1-MKK3 蛋白-蛋白相互作用 (PPI)抑制剂,抑制 TNF-α,通过与 MKK3 结合并破坏TAK1磷酸化MKK3来抑制TAK1/MKK3/p38/MnK1/MK2/elF4E信号通路。(R)-STU104 是治疗溃疡性结肠炎的候选化合物。
T6940 PHA-767491 hydrochloride

CAY10572,PHA-767491,PHA767491 HCl,CAY-10572 hydrochloride

Apoptosis; GSK-3; CDK Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells
PHA-767491 hydrochloride (CAY-10572 hydrochloride) 是一种Cdc7-Dbf4(DDK)/Cdk9的双重抑制剂,IC50值分别为 10 nM 和 34 nM。
T39321 CC-99677

CC99677,Gamcemetinib,CC 99677

HSP; MAPK Cytoskeletal Signaling; MAPK; Metabolism
CC-99677 (Gamcemetinib) 是一种一种用于自身免疫性疾病的选择性靶向共价MAPKAPK2(MK2)抑制剂,通过亲核芳族取代(SNAr)机制将生化效力转化为LPS活化的单核细胞THP-27细胞中热休克蛋白27(HSP1)磷酸化的有效抑制所显示的细胞效力。CC-99677 在大鼠实验中展现出在生化(IC 50 =156.3 nM)和细胞检测(EC 50 =89 nM)中均有
T5494 MW-150

MW01-18-150SRM

p38 MAPK; Autophagy Autophagy; MAPK
MW-150 (MW01-18-150SRM) 是一种选择性、CNS 渗透性和口服活性的 p38α MAPK 抑制剂,Ki 为 101 nM。它可抑制内源性 p38α MAPK 在活化的神经胶质中磷酸化内源性底物 MK2 的能力。
T62110 MK2-IN-4

MK2-IN-4 是一种 MAPKAPK2 (MK2) 抑制剂 (IC50: 45 nM)。MK2-IN-4 能够用于癌症、炎症和免疫学的研究。
T72202 Anti-inflammatory agent 33

Anti-inflammatory agent 33,一种有效的p38α抑制剂,抑制NO产生,并抑制LPS诱导的iNOS、COX-2、p-p38α、p-MK2蛋白表达,具有抗炎活性。
T39126 Zunsemetinib

CDD-450,ATI-450

Zunsemetinib (CDD-450) is a potent and specific inhibitor of the p38α-MK2 pathway, exerting its effects through oral administration. It has proven activity against immuno-inflammatory diseases, making it a valuable tool for research in this area.
T16721 Ralimetinib

LY2228820

Others Others
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor of p38 MAPK α/β (IC50s: 5.3 and 3.
T39343 MW-150 hydrochloride

MW01-18-150SRM hydrochloride,MW-150 hydrochloride

MW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a potent and selective inhibitor of p38α MAPK, with a Ki value of 101 nM. It exhibits excellent CNS penetration and oral bioavailability. MW-150 hydrochloride (MW01-18-150SRM hydrochloride) effectively suppresses the phosphorylation of MK2, a substrate of endogenous p38α MAPK, in activated glial cells.
T5487 MW-150 dihydrochloride dihydrate

MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) 是一种选择性的,可透过神经系统,具有口服活性的的p38α MAPK 抑制剂,Ki 值为 101 nM。MW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) 抑制内源性 p38α MAPK 磷酸化活化的神经胶质中内源性底物 MK2 的能力。
T76242 MMI-0100

MMI-0100 是一种细胞渗透性肽抑制剂,抑制丝裂原活化蛋白激酶活化蛋白激酶 II (MK2)。MMI-0100 在体内外减少内膜增生。MMI-0100 抑制IL-6表达而不影响IL-8表达。MMI-0100 抑制纤维化过程,例如静脉移植疾病。
T35536 Tpl2 Kinase Inhibitor (hydrochloride)

Tpl2 kinase inhibitor is an inhibitor of tumor progression locus 2 (Tpl2; IC50= 0.05 μM).1It is selective for Tpl2 over MEK, p38 MAPK, Src, MK2, and PKC (IC50s = >40, 180, >400, 110, and >400 μM, respectively). Tpl2 kinase inhibitor inhibits LPS-induced TNF-α production in isolated human monocytes and whole blood (IC50s = 0.7 and 8.5 μM, respectively). It enhances differentiation induced by calcitriol in HL-60 and U937 leukemia cells when used at a concentration of 5 μM.2Tpl2 kinase inhibitor (5...

化合物

MK2-IN-1
Cat.No: T36778
Synonym: MK2-IN-1 (MK2 Inhibitor)
Target:
MK2-IN-1 hydrochloride
Cat.No: T4442
Synonym: MK2 Inhibitor,MK 25
Target: MAPK
MK2-IN-3
Cat.No: T9034
Synonym: MK2 Inhibitor III
Target: MAPK
MK2-IN-3 hydrate
Cat.No: T12058
Synonym: MK-2 Inhibitor III
Target: ERK, MAPK, MNK
CMPD1
Cat.No: T14988
Synonym:
Target: MAPK
MK2-IN-5
Cat.No: T81783
Synonym: Hsp25 kinase inhibitor,Mk2 pseudosubstrate
Target: ERK
PF-3644022
Cat.No: T16501
Synonym:
Target: p38 MAPK, Serine Protease, MAPK
(R)-STU104
Cat.No: T60657
Synonym:
Target: TNF, MAPK
PHA-767491 hydrochloride
Cat.No: T6940
Synonym: CAY10572,PHA-767491,PHA767491 HCl,CAY-10572 hydrochloride
Target: Apoptosis, GSK-3, CDK
CC-99677
Cat.No: T39321
Synonym: CC99677,Gamcemetinib,CC 99677
Target: HSP, MAPK
MW-150
Cat.No: T5494
Synonym: MW01-18-150SRM
Target: p38 MAPK, Autophagy
MK2-IN-4
Cat.No: T62110
Synonym:
Target:
Anti-inflammatory agent 33
Cat.No: T72202
Synonym:
Target:
Zunsemetinib
Cat.No: T39126
Synonym: CDD-450,ATI-450
Target:
Ralimetinib
Cat.No: T16721
Synonym: LY2228820
Target: Others
MW-150 hydrochloride
Cat.No: T39343
Synonym: MW01-18-150SRM hydrochloride,MW-150 hydrochloride
Target:
MW-150 dihydrochloride dihydrate
Cat.No: T5487
Synonym:
Target:
MMI-0100
Cat.No: T76242
Synonym:
Target:
Tpl2 Kinase Inhibitor (hydrochloride)
Cat.No: T35536
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼